IDNNA

IDNNA
Names
	Preferred IUPAC name 1-(4-Iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
	Other names 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine; 2,5-Dimethoxy-4-iodo-1-ethyl-(α-methyl)amine
Identifiers
CAS Number	85563-10-6 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL11043 ;
ChemSpider	119009 ;
PubChem CID	135056;
UNII	M6Q9NK9RFD ;
CompTox Dashboard (EPA)	DTXSID901006121 ;
	InChI InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYSA-N ; InChI=1/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYAY;
	SMILES Ic1cc(OC)c(cc1OC)CC(N(C)C)C;
Properties
Chemical formula	C13H20NO2I
Molar mass	349.211 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

IDNNA (2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 2.6 mg, and the duration unknown.^[1] IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

References

^ IDNNA Entry in PiHKAL
^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

[1] IDNNA Entry in PiHKAL

[2] "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

[1]

[2]

Legality

United Kingdom

See also

References